Baosheng Posts $19.2M H1 Loss, Going-Concern Doubt, Nasdaq Deficiency Notice
BAOS is trading near its 52-week low of $0.16 (13% above the low) on light trading volume (0.3× avg).
Summary
Baosheng's H1 2026 net loss widened to $19.2 million on a 78% revenue collapse, with management flagging going-concern doubt, a Nasdaq bid-price deficiency, and a pending Cayman winding-up petition.
Key Events · Earnings and Guidance · BAOS
-
H1 2026 Net Loss Widens to $19.2M
Net loss of $19,221,741 for the six months ended June 30, 2026, versus $4,175,903 in H1 2025 — a 360% increase. Revenue collapsed 77.8% to $62,701 from $283,039.
-
Loss Driven by Non-Cash Charges
Selling and marketing expenses of $14,845,025 include $14,681,000 of non-cash share-based compensation for 5,300,000 shares issued to consultants on June 18, 2026. A further $2,723,858 impairment was taken on long-term investments.
-
Going-Concern Doubt Disclosed
Cash fell to $727,694 against $6,595,063 of current liabilities. Management says the June 8, 2026 private placement ($12,519,413 net) and bank borrowings keep it funded for 12 months, but the filing states these factors initially raised substantial doubt about the ability to continue as a going concern.
-
Nasdaq Bid-Price Deficiency Notice
Received September 10, 2026 after shares traded below $1.00 for 30 consecutive business days (July 27–September 9, 2026). The company has until March 9, 2027 to regain compliance.
Analysis · BAOS · Trade & Services
Baosheng's first-half 2026 results show a business barely operating: revenue fell 77.8% to $62,701 while the net loss ballooned to $19.2 million from $4.2 million a year earlier. Most of that loss is non-cash — $14.7 million of share-based compensation for 5.3 million shares handed to consultants, plus a $2.7 million write-off of two long-term investments — but the cash picture is still dire: only $727,694 of cash against $6.6 million of current liabilities. Management says a June private placement ($12.5 million) and bank borrowings keep it funded for 12 months, but the filing also discloses a Nasdaq minimum-bid deficiency notice (compliance deadline March 9, 2027), an active Cayman winding-up petition, a securities class action that survived dismissal, and a plan to sell RMB226.2 million of receivables for just RMB8.56 million — a 96% discount that shows how little the balance sheet is actually worth. The company is surviving on equity issuance, not operations.
How filings like this one have moved
In the 30 days to Oct 30, 2026, 38.3% of the 891 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BAOS was trading at $0.18 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $6M. The 52-week trading range was $0.16 to $4.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.